Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions.

Int J Health Sci (Qassim) · 2017 · PMC5669508 · PMID 29114186

Europe PMC

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP = 0.09so close (0.05 < p ≤ 0.1)

However, this difference did not reach statistical significance ( P = 0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.